These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 553752

  • 1. [Clinical study of thiadenol in diabetic hyperdyslipemia as compared with clofibrate].
    Nicrosini F, Pasotti C.
    Clin Ter; 1979 Aug 15; 90(3):241-50. PubMed ID: 553752
    [No Abstract] [Full Text] [Related]

  • 2. [Tolerability and side-effects of bis-(hydroxy-2-ethylthio)-1,10-decane (BS 530) as compared with clofibrate in the therapy of hyperlipemia].
    Colombo L, Monarca A, Goldberg D, Zanetta R.
    Clin Ter; 1979 Oct 31; 91(2):155-71. PubMed ID: 540479
    [No Abstract] [Full Text] [Related]

  • 3. [Bis-(hydroxy-2-ethylthyo)-1,10-decano in hyperlipaemic therapy (author's transl)].
    Cucinotta D, Palummeri E, Ceccato S, Passeri M.
    G Ital Cardiol; 1977 Oct 31; 7(3):248-64. PubMed ID: 858465
    [Abstract] [Full Text] [Related]

  • 4. [Hypolipidemic action of simfibrate in diabetic subjects].
    Gragnoli G, Tanganelli I, Signorini AM, Kristodhullu A.
    Clin Ter; 1981 Feb 28; 96(4):397-408. PubMed ID: 7214862
    [No Abstract] [Full Text] [Related]

  • 5. [Thiadenol in the short-term treatment of patients with blood lipid disorders].
    Di Stefano F, Patane S, Gatto A.
    Minerva Med; 1980 Mar 03; 71(8):567-74. PubMed ID: 7360386
    [Abstract] [Full Text] [Related]

  • 6. [Clinical trials with Fonlipol. Apropos of 50 cases].
    Warembourg H, Jaillard J.
    Lille Med; 1974 Apr 03; 19(4 Suppl 11):528-31. PubMed ID: 4612282
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of tiadenol in prolonged therapy of hyperlipoproteinemias (type IIa-IIb)].
    Rouffy J.
    Therapie; 1975 Apr 03; 30(6):815-23. PubMed ID: 785682
    [No Abstract] [Full Text] [Related]

  • 8. [Evaluation of the effects of tiadenol in various types of dyslipidemia].
    Saettone G, Cazzani E, Romanò M, Muzio L.
    Clin Ter; 1982 May 31; 101(4):387-93. PubMed ID: 7105643
    [No Abstract] [Full Text] [Related]

  • 9. [The clinical use of bis-(hydroxy-ethyl-thio)-1,10-decane in the treatment of hyperlipemic and dyslipemic conditions].
    Vailati G, Montini M, Simonutti M, Nosari I, Pagani G.
    Clin Ter; 1978 May 31; 85(4):361-73. PubMed ID: 668273
    [No Abstract] [Full Text] [Related]

  • 10. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
    Eisalo A, Manninen V.
    Proc R Soc Med; 1976 May 31; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196
    [No Abstract] [Full Text] [Related]

  • 11. [The management of hyperlipoproteinemia with Liproreduct].
    Fenster R.
    Ther Ggw; 1974 May 31; 113(5):813-24. PubMed ID: 4603893
    [No Abstract] [Full Text] [Related]

  • 12. [Indications and limitations of tiadenol therapy of dyslipidemia in the elderly].
    Passeri M, Cocchi C, Ceccato S, Palummeri E, Cucinotta D.
    G Clin Med; 1979 Jan 31; 60(1):49-64. PubMed ID: 456778
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)].
    Fourrier A, Mouton Y.
    Lille Med; 1974 Apr 31; 19(4 Suppl 11):532-7. PubMed ID: 4612283
    [No Abstract] [Full Text] [Related]

  • 14. A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.
    Tuomilehto J, Salonen J, Kuuisto P, Virtamo J, Manninen V, Mälkönen M.
    Proc R Soc Med; 1976 Apr 31; 69 Suppl 2(Suppl 2):38-40. PubMed ID: 798195
    [Abstract] [Full Text] [Related]

  • 15. [Clinical experimentation of clofibride. Apropos of 40 cases].
    Warembourg H, Jaillard J.
    Lille Med; 1973 Dec 31; 18(10 Suppl 5):suppl 5:1292-6. PubMed ID: 4802928
    [No Abstract] [Full Text] [Related]

  • 16. Clinical research into the hypolipemic and platelet antiaggregant activity of plafibride, Carried out in double-blind conditions and in comparison with clofibrate.
    Palmieri B, Gasparini Casari M, DiBlasio P, Zirilli E.
    Arzneimittelforschung; 1981 Dec 31; 31(10a):1863-6. PubMed ID: 7032534
    [Abstract] [Full Text] [Related]

  • 17. [Current trends in the therapy of arteriosclerotic disease].
    Toscano S.
    G Clin Med; 1974 Jan 31; 55(1):27-39. PubMed ID: 4369524
    [No Abstract] [Full Text] [Related]

  • 18. [Carbohydrate metabolism in bezafibrate therapy. Controlled study of glibenclamide-treated diabetics with hyperlipidemia].
    Janka HU, Standl A, Holler HD, Mehnert H.
    MMW Munch Med Wochenschr; 1982 May 28; 124(21):535-7. PubMed ID: 6810123
    [No Abstract] [Full Text] [Related]

  • 19. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM, Levy RI.
    Cardiovasc Clin; 1974 May 28; 6(2):1-8. PubMed ID: 4374303
    [No Abstract] [Full Text] [Related]

  • 20. [Therapeutic effects of bezafibrate in hyperlipidemia].
    Kunesová M, Honková M, Zeman M, Mares P, Skorepa J.
    Cas Lek Cesk; 1983 May 20; 122(20):628-31. PubMed ID: 6342789
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.